Inventor

KOSTURA MATTHEW J

US22 patents

⚠️ This page may combine multiple inventors who share the name “KOSTURA MATTHEW J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KOSTURA MATTHEW J

VTV THERAPEUTICS LLC

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Compounds that modulate oxidative stress

Compounds that modulate oxidative stress

Treatment of mild and moderate Alzheimer&#39;s disease

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

MJALLI ADNAN M M

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

MERCK & CO INC

Radioligand and binding assay

HIGH POINT PHARMACEUTICALS LLC

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

BANTAM PHARMACEUTICAL LLC

Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases

Treatment of mild and moderate Alzheimer's disease